Emmanouil Zoumakis

ORCID: 0000-0001-5234-0742 · 1 paper in corpus

lab-animal 2026

Galectin-3 as a Candidate Marker of Endocrine-modulator-associated Endometrial Remodeling During Breast Cancer Endocrine Therapy

·doi:10.21873/invivo.14494

Background/Aim: Breast cancer endocrine therapies may induce endometrial alterations, but the endometrial effects of antiprogestins remain incompletely defined. This study evaluated the effects of tamoxifen, mifepristone, and ulipristal ace…